Dermatologist care tied to better self-detection of melanoma

April 25, 2014
Dermatologist care tied to better self-detection of melanoma

(HealthDay)—Patients with self-detected primary melanoma who have an established dermatologist are more likely to have thinner lesions at the time of diagnosis, according to research published in the May issue of the Journal of the American Academy of Dermatology.

Michelle Y. Cheng, of the University of Pittsburgh School of Medicine, and colleagues conducted a retrospective cross-sectional study of 388 patients with primary to assess the association between the characteristics of dermatologic care and melanoma depth at diagnosis.

The researchers found that patients with an established , compared with those without an established dermatologist, were more likely to receive a diagnosis of melanoma in situ (63.6 versus 44.5 percent; P = 0.001) and have thinner invasive melanoma (0.48 versus 0.61 mm; P = 0.003). These patterns were observed for patients with self-detected, but not dermatologist-detected, melanoma. Self-detected melanomas were in situ for 59.0 percent of with an established dermatologist, compared with 37.0 percent of those without an established dermatologist (P = 0.006). Melanoma invasiveness or depth was not related to time from last dermatologic examination or wait time for an appointment.

"Education obtained at the dermatology appointment may improve early self-detection of melanoma, and having an established dermatologist may facilitate earlier evaluation of concerning lesions," the authors write.

Explore further: AAD: Older men should screen themselves for skin cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

AAD: Older men should screen themselves for skin cancer

March 1, 2013
(HealthDay)—Men aged 50 years or older are more likely to be diagnosed with invasive melanoma by a dermatologist than to detect it themselves; and they are less likely to seek a skin cancer screening due to a suspicious ...

Age-linked variation noted in melanoma management

August 15, 2013
(HealthDay)—Age-related variation is seen in the characteristics and management of melanoma, according to a study published online Aug. 14 in JAMA Dermatology.

Melanoma screening by physicians associated with finding more cancers than patient self-detection

July 18, 2011
Physician-based screening for melanoma is associated with higher rates of physician-detected melanoma and detection of thinner melanoma, according to a report published Online First today by Archives of Dermatology, one of ...

Melanoma up to 2.5 times likelier to strike transplant, lymphoma patients

October 3, 2012
Melanoma is on the rise nationally, and transplant recipients and lymphoma patients are far likelier than the average person to get that form of skin cancer and to die from it, a Mayo Clinic review has found. That is because ...

Stage III/IV melanoma patients at risk for new primaries

December 10, 2013
(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower than those observed ...

Risk of second primary melanoma up in pediatric patients

June 28, 2012
(HealthDay) -- Pediatric patients diagnosed with an invasive cutaneous melanoma have nearly double the relative risk of developing a subsequent primary melanoma, compared with adults, according to a study published online ...

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.